Most Recent
Purdue unit sued over patent extension for opioid Targin
Australian pharmaceutical company AUPharma has sued the international arm of Purdue, alleging it was wrongly granted patent extensions for several oxycodone products marketed as Targin. 
Government flags reforms to copyright laws
The federal government has foreshadowed a review of Australia’s copyright enforcement regime, citing the need to maintain “a healthy environment for artists.”
Maker of AFL merchandise sues US retail giant for trade mark infringement
Australian sports tour company FanFirm has sued US sports merchandise giant Fanatics alleging ‘flagrant’ infringement of its trade marks.
‘Not innocent’: Boart Longyear can’t avoid tool recall in patent infringement spat
Mineral exploration company Boart Longyear has been granted leave to appeal a finding that it infringed a patent for a mining tool, but it can't avoid a recall of its tools, with a judge saying its actions were “not uninformed or innocent”.
Freezing order stands in Sportsbet’s domain name spat with owner of sportsbet.com
Bookmaker Sportsbet has defeated a bid to overturn a freezing order against the owner of the sportsbet.com domain name in a trade mark infringement dispute stemming from a promotion agreement.
Griffith Hack sued by hospital operator over patent rights to stem cell invention
The operator of the Royal Perth Hospital has brought legal action against Griffith Hack alleging the law firm contributed to the "dishonest and fraudulent design" of a leading researcher to transfer the intellectual property rights to a stem cell manufacturing method developed inhouse.
Sukin accused of misleading consumers with carbon neutral labels
Eco-conscious Australian skincare company Sukin has been hit with a lawsuit alleging it misled consumers by selling products labelled with a carbon neutral certification it did not hold.
Car dealer software supplier Pentana accused of misusing market power
Titan DMS, which provides software to car dealers across Australia, has expanded cross claims in a legal dispute with leading competitor Pentana Solutions, alleging the rival engaged in misuse of market power by threatening dealers who want to switch providers.
Novartis, Pharmacor resolve suit over Gilenya patents
Novartis and and generic drug maker Pharmacor have resolved litigation over the Swiss pharmaceutical giant's patents for blockbuster MS drug Gilenya.
End of the road for AI inventions, as High Court rejects patent appeal
The High Court will not wade into the global debate over whether artificial intelligence inventions should receive patent protection, letting stand a Full Court judgment that overturned a landmark victory for AI pioneer Dr Stephen Thaler.